MohammadAmmad-Ud-DinMD

Internal Medicine • Tampa, FL

Hematology/Oncology

Physician

Join to view full profile

Dr. Ammad-Ud-Din is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ammad-Ud-Din's full profile

Already have an account?

Office
12902 USF Magnolia Drive
Tampa, FL 33612

Education & Training

Rochester General HospitalResidency, Internal Medicine, 2019 - 2022
Rawalpindi Medical CollegeClass of 2018

Certifications & Licensure

American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis.
Julio C Chavez, Ariel Grajales, Jose Sandoval-Sus, Elyce Turba, Lisa Nodzon
Clinical Lymphoma, Myeloma & Leukemia. 2024-06-01
7 citations
Geographic and Racial Disparities in Chimeric Antigen Receptor-T Cells and Bispecific Antibodies Trials Access for Diffuse Large B-Cell Lymphoma.
Moazzam Shahzad, Muhammad Fareed Khalid, Muhammad Kashif Amin, Ahmad Basharat, Mohammad Ammad-Ud-Din
Clinical Lymphoma, Myeloma & Leukemia. 2024-05-01
Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated myelodysplastic syndrome: A systematic review and meta-analysis.
Moazzam Shahzad, Qamar Iqbal, Ezza Tariq, Mohammad Ammad-Ud-Din, Atif Butt
Critical Reviews in Oncology/hematology. 2024-04-01